4-[(8-Cyclohexyl-2,8-diazaspiro[4.5]decan-2-yl)methyl]cyclohexan-1-one → 2-[2-[[4-[(8-cyclohexyl-2,8-diazaspiro[4.5]decan-2-yl)methyl]cyclohexyl]amino]-3-[1-(dimethylsulfamoyl)imidazol-2-yl]propyl]-N,N-dimethylimidazole-1-sulfonamide
반응식
[CH:1]1([N:7]2[CH2:8][CH2:9][C:10]3([CH2:11][CH2:12][N:13]([CH2:15][CH:16]4[CH2:17][CH2:18][C:19](=[O:22])[CH2:20][CH2:21]4)[CH2:14]3)[CH2:23][CH2:24]2)[CH2:2][CH2:3][CH2:4][CH2:5][CH2:6]1.[NH2:25][CH:26]([CH2:27][c:28]1[n:29]([S:33](=[O:34])(=[O:35])[N:36]([CH3:37])[CH3:38])[cH:30][cH:31][n:32]1)[CH2:39][c:40]1[n:41]([S:45](=[O:46])(=[O:47])[N:48]([CH3:49])[CH3:50])[cH:42][cH:43][n:44]1>>[CH:1]1([N:7]2[CH2:8][CH2:9][C:10]3([CH2:11][CH2:12][N:13]([CH2:15][CH:16]4[CH2:17][CH2:18][CH:19]([NH:25][CH:26]([CH2:27][c:28]5[n:29]([S:33](=[O:34])(=[O:35])[N:36]([CH3:37])[CH3:38])[cH:30][cH:31][n:32]5)[CH2:39][c:40]5[n:41]([S:45](=[O:46])(=[O:47])[N:48]([CH3:49])[CH3:50])[cH:42][cH:43][n:44]5)[CH2:20][CH2:21]4)[CH2:14]3)[CH2:23][CH2:24]2)[CH2:2][CH2:3][CH2:4][CH2:5][CH2:6]1참가 물질
3
반응물 2
생성물 1
출처 및 근거
- ORD 기록
- ord-9efaf43823cb4d53bf4ea137dbfda733
- 출처 데이터셋
- Training data from https://doi.org/10.1039/C8SC04228D (4/10)
- DOI